Olive View-UCLA Medical Center

Nancy Feldman MD

Division of Hematology and Oncology

Adjunct Professor of Medicine, David Geffen School of Medicine at UCLA

Dr. Nancy Feldman is board certified in Internal Medicine, Hematology, and Medical Oncology. Dr. Feldman received her MD from the University of California, San Diego. She completed her Internal Medicine residency and Hematology/Oncology fellowship training at Harbor-UCLA Medical Center. Dr. Feldman’s primary clinical interests are breast cancer, hematologic malignancies, psychosocial issues of cancer patients, genetic risk assessment, and survivorship issues. She developed a liaison with City of Hope to provide genetic risk assessment for our county patients >10 years ago. She is the site PI for the Avon Cares for Life, a breast cancer patient navigation program funded by the Avon Foundation through the UCLA Jonsson Comprehensive Cancer Center. She is a frequent invited speaker and has published in the above mentioned areas. Dr. Feldman’s primary love is teaching fellows to become great clinicians and humanistic hematologist/oncologists. Dr. Feldman has been at UCLA-Olive View for many years and enjoys treating our County population. She thrives on the wide variety of amazing cases that walk through the busy UCLA- Olive View doors.
Maggie Acosta MSN

Division of Hematology and Oncology

Oncology Nurse Practitioner, Special Treatment Center

Maggie Acosta received her Masters of Science in Nursing from UCLA. She currently serves patients in the Special Treatment Center at Olive View-UCLA Medical Center.
Martina Zalom MD

Division of Hematology and Oncology

Assistant Professor of Medicine, David Geffen School of Medicine at UCLA

Dr. Martina Zalom is board certified in Internal Medicine, Hematology, and Medical Oncology. She received her MD from University of California, San Diego and completed her Internal Medicine residency at Cedars-Sinai Medical Center. She completed her Hematology-Oncology fellowship training at the UCLA-Olive View / Cedars-Sinai / Kaiser Los Angeles program. Prior to joining the faculty at Olive View, she worked at East Valley Hematology and Oncology practice at the Roy and Patricia Disney Family Cancer Center. She is interested in hematologic malignancies, general oncology with a focus on GI malignancies. She additionally supervises fellow research projects and is active in clinical trial recruitment.
Phillis Wu MD

Hematology and Oncology Fellowship Associate Program Director

Division of Hematology and Oncology

Assistant Professor of Medicine, David Geffen School of Medicine at UCLA

Dr. Phillis Wu is board certified in Internal Medicine, Hematology, and Medical Oncology. She received her MD from University of California, San Diego and completed her Internal Medicine residency at Olive View-UCLA Medical Center and also served as chief resident. She completed her Hematology/Oncology fellowship training at the UCLA-Olive View / Cedars-Sinai / Kaiser Los Angeles program. She is interested in hematologic malignancies and general oncology with a focus on gynecology/oncology.
Leland Powell MD, PhD, FACP

Division of Hematology and Oncology

Vice-Chair, Department of Medicine, Olive View-UCLA Medical Center

Professor of Medicine, David Geffen School of Medicine at UCLA

Dr. Leland Powell has been a member of the Division of Hematology-Oncology since 2001, joining the faculty after three years in private practice hematology/oncology in the San Fernando Valley and seven years on faculty at UCSD. He received his MD and PhD degrees at Johns Hopkins School of Medicine, completed his residency training at Beth Israel Hospital, Boston, and then moved to San Diego to complete a post-doctoral fellowship and his clinical fellowship training at UCSD. He stayed on there as faculty doing research on carbohydrate-binding proteins in hematopoietic cells while developing clinical trials in GU cancers and working in the Division of Hematology-Oncology at the San Diego VAMC. He moved to the San Fernando Valley to work in a clinical practice affiliated with the clinical trials organization at UCLA before moving on to Olive View-UCLA Medical Center. As the only public safety-net hospital serving a patient catchment area the size of Pittsburgh, he has found it both clinically fulfilling and an excellent teaching venue. During his tenure at OVMC, he has worked in the Division of Hematology-Oncology, served five years as the Associate Medical Director, and currently serves as Vice Chair, Department of Medicine, along with continuing his affiliation with the Division of Hematology-Oncology. His administrative duties include the Quality Improvement Committee, Risk Management Committee, and multiple ad hoc safety committees. He additionally coordinates the performance improvement projects conducted by all of the hematology-oncology fellows. His specific interests are systems approaches to quality in health care delivery along with effective health-care delivery in resource-constrained systems.
Jeffrey M. Miller MD

Hematology and Oncology Fellowship Program Director

Interim Chief of Hematology and Oncology

Associate Professor of Medicine, David Geffen School of Medicine at UCLA

Member, Jonsson Comprehensive Cancer Center-Stem Cell Biology Program Area

Dr. Jeffrey M. Miller is board certified in Internal Medicine, Hematology, Medical Oncology, and Palliative Care. He received his MD from Ross University and completed his Internal Medicine residency at Seton Hall University. He completed his Hematology-Oncology fellowship training at the University of Maryland Cancer Center. He is interested in hematologic malignancies, general oncology and palliative care. He coordinates the core curriculum series and journal club for the fellowship program and greatly enjoys teaching our fellows and housestaff. He is active in clinical research trial recruitment at OVMC.
Natasha Banerjee MD

Division of Hematology and Oncology

Assistant Professor of Medicine, David Geffen School of Medicine at UCLA

Dr. Natasha Banerjee received her MD from University of Toledo College of Medicine and completed her Internal Medicine residency at Harbor-UCLA Medical Center. She completed her Hematology-Oncology fellowship training at the UCLA-Olive View / Cedars-Sinai / Kaiser Los Angeles program. She is board certified in Internal Medicine, Hematology, and Medical Oncology. She is interested in hematologic malignancies and general oncology with a focus on head and neck and thoracic malignancies. She additionally assists in coordinating the performance improvement projects for the hematology/oncology fellows.

Cedars-Sinai Medical Center: Core Faculty

Ronald Paquette MD

Blood and Marrow Transplant

Dr. Ron Paquette is a member of the Blood and Marrow Transplant Program at Cedars-Sinai. He is a physician and researcher who treats patients with hematologic disorders including aplastic anemia, myelodysplastic syndrome, leukemias and lymphomas. He attended medical school at The Ohio State University, completed his Internal Medicine residency and Hematology-Oncology fellowship at the University of California, Los Angeles. He was previously a faculty member at UCLA before joining Cedars-Sinai Medical Center.
Monica Mita MD

Co-Director, Experimental Therapeutics Program

Dr. Monica Mita is co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. After earning her medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, she completed specialty training in cancer research at Paul Brousse Hospital in Villejuif, France and the Rene Huguenin Center in Saint-Cloud, France. She received additional specialty training in oncology at the Claudius Regaud Center, Purpan Hospital, the Saint-Antoine Hospital and Childrens Hospital, in France. She performed a fellowship in medical oncology and one in Advanced Oncology Drug Development at the University of Texas.Dr. Mita’s research focuses on the development of early clinical trials of novel therapeutic agents. Dr. Mita has authored more than 53 articles published in peer reviewed publications. She has presented 82 abstracts and poster presentations and has lectured at numerous conferences and meetings. In addition to being a member of the European Society for Medical Oncology and the French Medical Board in Internal Medicine, Dr. Mita is a member of the American Society for Clinical Oncology, the American Association for Cancer Research and the Southwest Oncology Group, Breast and Early Therapeutics. She earned a diploma at the School of Breast Oncology in Atlanta, Georgia and both a merit award and the Brigid G. Leventhal Award from the American Society of Clinical Oncology.
Alain Mita MD

Co-Director, Experimental Therapeutics Program

Dr. Alain Mita is co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. He obtained his undergraduate bachelor’s degree as well as his M.D. in Bucharest, Romania. He completed fellowship training in Medical Oncology at the Paul Sabatier University in Toulouse, France, and at The University of Texas Health Science Center San Antonio and an Advanced Fellowship in Drug Development at the Institute for Drug Development at CTRC. Dr. Mita has a long-standing interest and expertise in the treatment of lung cancer, more specifically in the development of new drugs for this disease.
Noah M. Merin MD

Blood and Marrow Transplant

Dr. Noah Merin is a member of the Blood and Marrow Transplant Program at Cedars-Sinai. He is board certified in Internal Medicine, Hematology and Oncology. He attended medical school at the University of California, Davis followed by Internal Medicine Residency at Harbor-UCLA Medical Center. He completed his fellowship training at University of Southern California where he also served as Chief Fellow for Hematology. He was a clinical instructor at USC/Norris Cancer Hospital for the Division of Hematology before joining Cedars-Sinai Medical Center faculty. His research focus is on immune system and cancer, haploidentical stem cell transplantation, and transplantation for lymphoid malignancies.
Yuliya P. L. Linhares MD

Blood and Marrow Transplant

Dr. Yuliya P. L. Linhares is a member of the Blood and Marrow Transplant Program at Cedars-Sinai. She is board certified in Internal Medicine, Hematology and Oncology. Dr. Linhares research focus is in cancer and cancer therapeutics. She has published articles in peer reviewed journals on issues related to blood and marrow transplants. After attending Saint Petersburg State Medical University in Saint Petersburg, Russia. Dr. Linhares earned a B.S. in biology at Lenoir Rhyne in Hickory, North Carolina, magna cum laude. She earned her medical degree with distinction, from the University of North Carolina, Chapel Hill School of Medicine in Chapel Hill. She went on to perform her internship and residency in internal medicine and a fellowship in hematology-oncology at the University of California, Los Angeles. Other fellowships completed include the California Institute of Regenerative Medicine and the National Institutes of Health fellowships at the Howard Hughes Medical Institute for BMT Research and Continued Research.
Michael Lill MD

Hematologist/Oncologist

Medical Director, Blood and Marrow Transplant Program

Prior to joining Cedars-Sinai, Dr. Lill served as Director of the Core Laboratory for Cellular and Gene Therapy at the University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center and was Medical Director of the UCLA Cord Blood Bank. Dr. Lill’s research interests focus on myelodysplastic syndrome (MDS), bone marrow and peripheral blood stem cell transplantation, cord blood transplantation, hematologic disorders, leukemia, lymphoma and growth factors. He currently has an active program in bloodless transplantation for Jehovah’s Witnesses and is collaborating with cardiology to provide bone marrow stem cells for repair of the heart. Dr. Lill is listed as one of the "Best Doctors in America," as well as one of the "Best Cancer Doctors in America" in 2005, 2006 and 2007. He is Chair of the Bone Marrow Transplant Committee at Cedars-Sinai, which reviews cases presented for transplantation. He served as Chair of the Cedars-Sinai Cancer Committee and the Hematology/Radiation Oncology Performance Improvement Committee from 1997 to 1999. Dr. Lill has published numerous articles on bone marrow and stem cell transplantation in peer-reviewed journals, such as the British Journal of Haematology, Blood, Bone Marrow Transplantation, Leukemia, Journal of the National Cancer Institute and Journal of Hematotherapy. He has written book chapters for Cancer Treatment, Cell Therapy and On Call In Bone Marrow Transplantation. Dr. Lill also served as a reviewer for several journals, including Blood, Bone Marrow Transplantation and Hematopoietic Therapy Index and Reviews. Dr. Lill received his bachelor’s and medical degrees from the University of Western Australia, Perth. He completed his internship, residency and fellowship training at Sir Charles Gairdner Hospital in Nedlands, Western Australia. His fellowship training continued at the Royal Perth Hospital, Perth, Western Australia. In 1989 he joined the University of California, Los Angeles as a visiting clinical instructor and later as a full-time clinical instructor.
Robert Figlin MD, FACP

Hematology and Oncology Fellowship Site Coordinator

Professor of Medicine and Biomedical Sciences

Steven Spielberg Family Chair in Hematology Oncology

Director, Division of Hematology Oncology

Deputy Director, Samuel Oschin Comprehensive Cancer Institute

Dr. Robert Figlin is Professor of Medicine and Biomedical Sciences, Director of the Division of Hematology Oncology and Deputy Director at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. He holds the Steven Spielberg Family Chair in Hematology Oncology. Dr. Figlin is board-certified in both medical oncology and internal medicine. Dr. Figlin previously served as Professor and Chair of the Department of Medical Oncology and Therapeutic Research at City of Hope. He also was affiliated with the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA) for more than 20 years, where he held a number of leadership positions in the areas of urologic cancer, hematology/oncology and thoracic oncology. Dr. Figlin is a prolific researcher known for advancing urologic and lung cancer therapies. His expertise has resulted in the development of novel anti-cancer drugs that have led to improved outcomes for patients. Dr. Figlin has written more than 300 peer-reviewed publications, authored several books on kidney cancer and published more than 60 book chapters on new approaches to cancer treatment. He is a fellow of the American College of Physicians and the International Society for Biologic Therapy as well as a member of the American Society of Clinical Oncology, the American Association for Cancer Research, the National Comprehensive Cancer Center Network and the American Urological Association. Dr. Figlin earned his bachelor’s degree in chemistry from Temple University, where he also earned a graduate degree in organic chemistry. He earned his medical degree from the Medical College of Pennsylvania. Dr. Figlin served his internship and residency at Cedars-Sinai Medical Center where he was Chief Medical Resident and completed a fellowship in Hematology-Oncology at UCLA.

Additional Faculty at Cedars-Sinai

Kaiser Permanente Los Angeles Medical Center: Core Faculty

Roberto Rodriguez MD

Chair, Hematology and Medical Oncology

Dr. Roberto Rodriguez is board certified in Medical Oncology. He received his MD at the Universidad Javeriana in Bogota, Colombia. He completed his residency training at La Guardia Hospital and Pennsylvania Hospital. and fellowship in Hematology-Oncology at the University of Pennsylvania School of Medicine and completed additional training in oncology at USC and in bone marrow transplantation at the City of Hope, where he stayed on as associate professor until 2007. He joined Kaiser Permanente Los Angeles in 2007. He is interested in general oncology.
Sameer Kulkarni MD

Kaiser Permanente Physician

Dr. Sameer Kulkarni received his MD from Albert Einstein School of Medicine in New York, Internal Medicine residency at University of California, Los Angeles and Hematology-Oncology fellowship training at the UCLA-Olive View / Cedars-Sinai / Kaiser Los Angeles program. He is interested in hematologic malignancies and general oncology and serves as the fellowship curriculum liaison for the fellowship program where he continues his passion for teaching.
Iman A. Abdalla MD

Kaiser Permanente Physician

Dr. Iman Abdalla is board certified in Hematology and Medical Oncology. She received her MD from George Washington University Medical Center. She completed her residency training and fellowship training at George Washington University Medical Center as well. She is interested in general oncology.
Karen W. Kwan MD

Hematology and Oncology Fellowship Site Coordinator

Kaiser Permanente Physician

Dr. Karen Kwan is board certified in Internal Medicine, Hematology, and Medical Oncology. She received her MD from University of California, Davis. She completed her residency, chief residency, and fellowship in Hematology-Oncology at Harbor-UCLA Medical Center. She is interested in general oncology.
Alexander Shar MD

Kaiser Permanente Physician

Dr. Alexander Shar is board certified in Hematology and Medical Oncology. He received his MD from Moscow I.I. Sechenov Medical Academy. He completed his residency training at Abbott Northwestern Hospital in Minneapolis and fellowship in Hematology-Oncology at the University of Minnesota School of Medicine. His interests include benign hematology.